The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation
about
Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions.Acute myeloid leukemia: treatment of adults under 60 years.Current controversies: which patients with acute myeloid leukaemia should receive a bone marrow transplantation?--an adult treater's view.Prospects for immunotherapy of malignant disease.Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma.Novel approaches in GVHD therapy.Titrating graft-versus-host disease: is it worth a try?The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.Phase-1 study of siplizumab in the treatment of pediatric patients with at least grade II newly diagnosed acute graft-versus-host disease.Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation.Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances.Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation.General health, symptom occurrence, and self-efficacy in adult survivors after allogeneic hematopoietic stem cell transplantation: a cross-sectional comparison between hospital care and home care.Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.Effect of graft-versus-host disease on the outcome of bone marrow transplantation from an HLA-identical sibling donor using GVHD prophylaxis with cyclosporin A and methotrexate.Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution.Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis.Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease.Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBI.Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors.Salivary secretion in children after fractionated or single-dose TBI.Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.
P2860
Q33577929-532B9308-6DFB-435C-9E6D-6C7B571A3A20Q34680933-AE2D17F5-A5B1-4841-BEF7-2E3C71E1E9C3Q34760577-7AAD72FC-EFDB-48A9-AA0A-DC6961B210D4Q35041705-97571997-0A71-4679-AFDC-E044562CB2A5Q36013444-B80AC05C-8FB2-424E-8836-247FB7F3AA77Q36090227-A0156A32-BBAC-4A0B-B95D-35C5EEEEC503Q36605959-2FAA07C5-9F52-4FD3-836D-C1EC49F4694BQ37143670-CA963BCF-555D-4A4A-89E7-F1AD5CB5FC49Q40382580-C0F54D93-0861-4839-A65A-06FD7D216067Q40599078-920BF56C-C210-4210-84F2-8D474D824D1EQ41465330-67E24309-9CC0-4998-8447-BB45691D6C03Q41668011-B4B9893E-C39C-4B20-813E-98571AABE262Q43885610-1807CA99-5225-4561-B976-33FCA156B16EQ43988469-1DAD5C89-C92E-4D2C-BB9C-CCE9466EC46BQ44024542-87C32388-C8A8-42D7-A0D6-FB42108FA2BCQ44094549-3ED046F2-A7F3-4361-861E-1AC9D2A0345CQ44331222-19F89EDD-161E-4CE5-96A4-D89B52232120Q44477645-481294AC-6735-4348-A7B4-D309C0EC86B9Q47140612-5E4FBC83-D2E6-41DA-9BD0-E8A97B981084Q51443713-A12ED626-CC2E-4B3C-98B3-6128D296203AQ52008592-F7D0C77C-38F1-4D69-B65D-AE61FA577E3AQ53249497-79D99A31-FF15-4757-83E8-46B815D2D18FQ53365188-B07B530E-C070-4737-AC56-AD4B12B70B53Q53665940-4A06963E-02DC-4DC3-9A3D-CF5A41C4A853
P2860
The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
The highest leukaemia-free sur ...... ood and Marrow Transplantation
@en
The highest leukaemia-free sur ...... ood and Marrow Transplantation
@nl
type
label
The highest leukaemia-free sur ...... ood and Marrow Transplantation
@en
The highest leukaemia-free sur ...... ood and Marrow Transplantation
@nl
prefLabel
The highest leukaemia-free sur ...... ood and Marrow Transplantation
@en
The highest leukaemia-free sur ...... ood and Marrow Transplantation
@nl
P2093
P2860
P1433
P1476
The highest leukaemia-free sur ...... ood and Marrow Transplantation
@en
P2093
P2860
P356
10.3109/10428199609045715
P577
1996-12-01T00:00:00Z